Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
 
 
Cost-effectiveness analysis of hexaminolevulinate in non-muscle invasive bladder cancer patients in Italy
Pharmerit conducted an analysis to estimate the incremental cost-effectiveness of hexaminolevulinate for patients diagnosed with non-muscle invasive bladder cancer (NMIBC) in Italy
 
Pharmerit publishes study on the costs of anal cancer in England
Despite its rarity, anal cancer places a significant economic burden on the public purse and moreover resource pressures on the national health service.
 
Internship AMNOG (DE)
We are currently seeking an intern for our office in Berlin, Germany. Your main job will be support of our in-house AMNOG database.
 
Partially Hydrolyzed Formula (pHF-W) was predicted to result in a reduction in the burdens of atopic dermatitis
In the first study examining pHF-W vs. CMF in an Asian country, Pharmerit, Nestlé Nutrition and affiliates found pHF-W to be a cost effective alternative for atopic dermatitis.
 
Study highlights limited data reported on treatment efficacy for less common Neuropathic Pain (NeP) conditions
Guideline-recommended treatments for PHN are more effective vs. placebo. Additional evaluations for less common NeP conditions are required, despite published treatment guidelines.
 

 Latest news

 
2015-03-03
Pharmerit Europe has a new management team of Bram Verheggen, Maarten Treur, and Stephanie Stephens. Together they are responsible for all aspects of Pharmerit Europe, but each has their own key focus.
2015-01-06
Pharmerit conducted an analysis to estimate the incremental cost-effectiveness of hexaminolevulinate for patients diagnosed with non-muscle invasive bladder cancer (NMIBC) in Italy
2014-12-15
Despite its rarity, anal cancer places a significant economic burden on the public purse and moreover resource pressures on the national health service.
 

 Our people

 
“Look at a day when you are supremely
satisfied at the end.  It's not a day when
you lounge around doing nothing; it's
when you've had everything to do,
and you've done it„
 
“It is rewarding to work with a
multidisciplinary team of
researchers who collaborate
to bring the best out of every
project„
 
“Just work is boring. Add some
purpose and challenge, and it
becomes fun„
 
“The fun part is working on
a diverse array of projects
and understanding how
different bits fit together to
form a complete picture„
 
 
 

 Meet us at

 
Apr
07
2015
San Diego, CA (USA)09:00 - 17:00
May
16
2015
Philadelphia, PA (USA)21:00 - 21:00
Aug
23
2015
Boston, MA (USA)11:00 - 11:00
Sep
06
2015
Santiago (Chile)09:00 - 17:00
Oct
07
2015
Providence, Rhode Island (USA)09:00 - 17:00
Retrieving Data